CDC: Increase in Prevalence of Walking in the United States

Share this content:
CDC: Increase in Prevalence of Walking in the United States
CDC: Increase in Prevalence of Walking in the United States

(HealthDay News) -- The prevalence of walking (defined as walking for leisure or transportation in at least one bout of 10 minutes or more in the last week) increased in the United States from 2005 to 2010, with an increased likelihood of meeting the aerobic physical activity guideline noted for walkers, according to a study published in the Aug. 7 early-release issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly.

To examine changes in the prevalence of walking, David Berrigan, Ph.D., from the National Cancer Institute in Bethesda, Md., and colleagues analyzed data from the 2005 and 2010 National Health Interview Surveys. The correlation between walking and meeting the aerobic physical activity guideline was examined.

The researchers noted a significant increase in the prevalence of walking, from 55.7 percent in 2005 to 62.0 percent in 2010. In most of the demographic and health characteristic categories examined, walking prevalence was significantly higher. Compared with non-walkers, among walkers, the adjusted odds ratio of meeting the aerobic physical activity guideline was 2.95 in 2010.

"To sustain increases in the prevalence of walking, communities can implement evidence-based strategies such as creating or enhancing access to places for physical activity, or using design and land use policies and practices that emphasize mixed-use communities and pedestrian-friendly streets," the authors write. "Public health efforts to promote walking as a way to meet physical activity guidelines can help improve the health of U.S. residents."

Full Text

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs